In recent years hundreds of unregulated stem cell treatment centers have cropped up across the U.S. These clinics claim to offer treatments for a wide variety of diseases and ailments by using patients’ own stem cells. These centers often use high-pressure sales tactics to prey on individuals and …
New FDA designation opens the door for stem cell trials
Dr. Temple contributed to a recent article on a stem cell clinical trial that has recently received the Food and Drug Administration's new Regenerative Medicine Advanced Therapy (RMAT) designation. Read more about how this new designation will help to promote the advancement of legitimate stem …
Dr. Messer hosts webinar for “The Scientist”
Dr. Anne Messer was one of two experts chosen to present a webinar for The Scientist (March 8, 2018.) Antibodies are the fastest growing class of synthetic therapeutics, and Dr. Messer's presentation covered their development and use as therapeutics and markers for neurodegenerative diseases. She …
Support NSCI on November 28th, #GivingTuesday
Celebrate your kindness on #GivingTuesday. On #GivingTuesday, a national day of donation, consider a gift to the Neural Stem Cell Institute. Your gift gets us closer to therapies for incurable diseases of the central nervous system including Macular Degeneration, Alzheimer's, Parkinson's, Spinal …
NSCI Researchers Presenting at NYAS
This week Dr. Boles and Dr. Kiehl will be attending a workshop on "Data Science, Learning, and Applications to Biomedical & Health Sciences" at the New York Academy of Sciences (NYAS) in New York City. This workshop is jointly sponsored by the National Science Foundation, Rutgers Institute for …